DALLAS -- Fewer than half of patients were prescribed a dual antiplatelet therapy (DAPT) regimen after minor stroke or transient ischemic attack (TIA), a population-based registry showed. For strokes ...
Bayer announces publication of full results from pivotal phase III OCEANIC-STROKE study of FXIa inhibitor, asundexian in The New England Journal of Medicine: Berlin Friday, April ...
In OCEANIC-STROKE, patients who received asundexian after a non-cardioembolic ischemic stroke or high-risk transient ischemic attack were significantly less likely to suffer a secondary stroke ...
Among patients hospitalized with a first ischemic stroke, 80% were rehospitalized, primarily because of subsequent primary cardiovascular and cerebrovascular diagnoses. To gather information on ...
Basel, Switzerland: In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine ...
Left atrial appendage occlusion (LAAO) during cardiac surgery in patients with atrial fibrillation was associated with lower stroke-related disability and reduced risk for 30-day mortality and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results